Results 51 to 60 of about 4,210,891 (389)

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)

Harm Reduction Journal, 2022
Background Australia has had a framework for legal medicinal cannabis since 2016, yet prior online surveys in 2016 and 2018 indicated that most consumers continued to use illicit medical cannabis products.
N. Lintzeris, Llewellyn Mills, Sarah V. Abelev, Anastasia S. Suraev, J. Arnold, I. McGregor   +5 more
semanticscholar   +1 more source

Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study

Frontiers in Medicine, 2022
Background Despite the absence of rigorous prospective studies, there has been an increase in the use of cannabis-based medicinal products. During the study period, the use of medical cannabis in Israel was tightly regulated by national policy. Through a
Lihi Bar-Lev Schleider, R. Mechoulam, Inbal Sikorin, T. Naftali, V. Novack   +4 more
semanticscholar   +1 more source

Use of Medicinal Cannabis and Synthetic Cannabinoids in Posttraumatic Stress Disorder (PTSD): a systematic review [PDF]

, 2019
Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances.
Chiappini, Stefania, Corkery, John, De Berardis, Domenico, Latini, Roberto, Orsolini, Laura, Papanti, Gabriele Duccio, Volpe, Umberto   +6 more
core   +2 more sources

Nitrogen Source Matters: High NH4/NO3 Ratio Reduces Cannabinoids, Terpenoids, and Yield in Medical Cannabis

Frontiers in Plant Science, 2022
The N form supplied to the plant, ammonium (NH4+) or nitrate (NO3–), is a major factor determining the impact of N nutrition on plant function and metabolic responses. We have hypothesized that the ratio of NH4/NO3 supplied to cannabis plants affects the
Avia Saloner, N. Bernstein
semanticscholar   +1 more source

California cannabis regulation: An overview [PDF]

, 2019
In 2016, Proposition 64 decriminalized the possession and use of cannabis by anyone in California aged 21 or over. But the 2015 Medical Marijuana Regulation and Safety Act had begun the process of regulating cannabis in the ...
Goldstein, Robin, Sumner, Daniel A
core   +1 more source

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process

Journal of Cannabis Research, 2021
Background Globally, medical cannabis legalization has increased in recent years and medical cannabis is commonly used to treat chronic pain. However, there are few randomized control trials studying medical cannabis indicating expert guidance on how to ...
A. Bhaskar, A. Bell, M. Boivin, Wellington Briques, Matthew Brown, H. Clarke, C. Cyr, E. Eisenberg, Ricardo Ferreira de Oliveira Silva, E. Frohlich, Peter Georgius, M. Hogg, T. Horsted, Caroline A. MacCallum, K. Müller-Vahl, Colleen O’Connell, Robert Sealey, M. Seibolt, Aaron Sihota, Brennan K Smith, Dustin Sulak, A. Vigano, D. Moulin   +22 more
semanticscholar   +1 more source

Cannabis-based medicines and medical cannabis for adults with cancer pain.

Cochrane Database of Systematic Reviews, 2022
BACKGROUND Pain is a common symptom in people with cancer; 30% to 50% of people with cancer will experience moderate-to-severe pain. This can have a major negative impact on their quality of life.
W. Häuser, P. Welsch, L. Radbruch, E. Fisher, R. Bell, R. Moore   +5 more
semanticscholar   +1 more source

UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment. [PDF]

Pain Pract
Datta I, Erridge S, Holvey C, Coomber R, Guru R, Holden W, Darweish Medniuk A, Sajad M, Searle R, Usmani A, Varma S, Rucker JJ, Platt M, Sodergren MH.   +13 more
europepmc   +2 more sources

Shifts in medical cannabis use in Canada during the COVID-19 pandemic

Health Promotion and Chronic Disease Prevention in Canada, 2023
IntroductionThe COVID-19 pandemic has had widespread secondary negative health impacts including loss of material security and exacerbation of mental illness in at-risk populations.
Stephanie Lake, Ziva D. Cooper, Kaye Ong, Philippe Lucas   +3 more
doaj   +1 more source

Cannabinoids in the treatment of epilepsy: current status and future prospects [PDF]

, 2020
Cannabidiol (CBD) is one of the prominent phytocannabinoids found in Cannabis sativa, differentiating from Δ9-tetrahydrocannabinol (THC) for its non-intoxicating profile and its antianxiety/antipsychotic effects.
Albini M., Cifelli P., Di Bonaventura C., Fanella M., Giallonardo A. T., Morano A., Palma E.   +6 more
core   +1 more source